SCHEMBL6640607

SCHEMBL6640607

[c]1cccc(-c2ccccc2)c1CNCC1CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
CYP2C19 P33261 2/20 0.42
KMT2A Q03164 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
RECQL P46063 1/20 0.42
IDO1 P14902 1/20 0.39
CXCR4 P61073 1/20 0.38
CD274 Q9NZQ7 1/20 0.36
HDAC1 Q13547 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325686 0.85 PIM1 (0.41) CYP2C19CYP2D6CYP2C9IDO1CXCR4
SCHEMBL6320544 0.83 CYP2D6 (0.35) MEN1CYP2C19KMT2ATP53CYP3A4
SCHEMBL6322319 0.80 MEN1 (0.37) MEN1CYP2C19KMT2ATP53CYP3A4
SCHEMBL6321221 0.80 GPR39 (0.42) MEN1CYP2C19KMT2ATP53CYP3A4
SCHEMBL21408620 0.79 MEN1 (0.49) MEN1KMT2ACD274HDAC1ALDH1A1
SCHEMBL6643602 0.77 KMT2A (0.41) MEN1CYP2C19KMT2ATP53CYP3A4
SCHEMBL6636865 0.77 MEN1 (0.43) MEN1KMT2ACD274ALDH1A1HTT
SCHEMBL6640137 0.77 KMT2A (0.43) MEN1KMT2ACD274ALDH1A1HTT
SCHEMBL19692916 0.74 KDM4E (0.39) MEN1KMT2ACYP3A4CD274ALDH1A1
SCHEMBL5796914 0.73 ALDH1A1 (0.41) MEN1KMT2ACD274ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140871-A4 THROMBIN OR FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-05-06 EP disclosed
EP-1140871-A1 THROMBIN OR FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
EP-1140941-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2000039108-A1 THROMBIN OR FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO disclosed
WO-2000039131-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO disclosed